Sveriges mest populära poddar

Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

46 min•12 oktober 2023

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.

Fler avsnitt av Hematologic Oncology Update

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

1 apr.•25 min

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

23 mars•24 min

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

21 mars•29 min

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

13 mars•1 tim 3 min

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

11 mars•47 min

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

9 mars•19 min

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

4 mars•24 min

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

18 feb.•58 min

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

13 feb.•17 min

Immune Thrombocytopenia — ASH 2025 Review

6 feb.•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.